Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patientsRebecca Evans, Haruhide Kimura, Robert Alexander, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2012
Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective studyYukihiro Sanada, Koichi Mizuta, Taizen Urahashi, et al.Journal of Cardiology|July 22, 2008
Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?Shinichiro Tanaka, Kazuhiko Nishigaki, Shinsuke Ojio, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2008
Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasoundMunenori Okubo, Masanori Kawasaki, Yoshiyuki Ishihara, et al.JAMA Neurology|December 8, 2025
Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical TrialGert Jan Lammers, Giuseppe Plazzi, Emmanuel Mignot, et al.The New England Journal of Medicine|May 14, 2025
Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, et al.Pageof 6